Assembly Biosciences ASMB Accrued liabilities
Accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccruedLiabilities.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Assembly Biosciences's accrued liabilities?
- Assembly Biosciences (ASMB) reported accrued liabilities of -$5.09M in Q1 2026.
- How has Assembly Biosciences's accrued liabilities changed year-over-year?
- Assembly Biosciences's accrued liabilities decreased by 11.5% year-over-year, from -$4.56M to -$5.09M.